Emulating the natural timing of dopamine receptor activation in Parkinson's Disease

被引：0
|
作者：
Reynolds, J.
Hyland, B.
Wickens, J.
Tan, E.
机构：
来源：
MOVEMENT DISORDERS | 2018年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
225
引用
收藏
页码：S99 / S99
页数：1
相关论文
共 50 条
  • [21] The Influence of Dopamine on Automatic and Controlled Semantic Activation in Parkinson's Disease
    Arnott, Wendy L.
    Copland, David A.
    Chenery, Helen J.
    Murdoch, Bruce E.
    Silburn, Peter A.
    Angwin, Anthony J.
    PARKINSONS DISEASE, 2011, 2011
  • [22] Microglial activation and dopamine terminal loss in early Parkinson's disease
    Ouchi, Y
    Yoshikawa, E
    Sekine, Y
    Futatsubashi, M
    Kanno, T
    Ogusu, T
    Torizuka, T
    ANNALS OF NEUROLOGY, 2005, 57 (02) : 168 - 175
  • [23] Dopamine Receptor Agonists for the Treatment of Early or Advanced Parkinson’s Disease
    Santiago Perez-Lloret
    Olivier Rascol
    CNS Drugs, 2010, 24 : 941 - 968
  • [24] Dopamine and adenosine receptor interaction as basis for the treatment of Parkinson's disease
    Morelli, M
    Carta, AR
    Annalisa, P
    Elisabetta, T
    Nicola, S
    MOVEMENT DISORDERS, 2004, 19 : S387 - S387
  • [25] ASSOCIATION OF DOPAMINE RECEPTOR GENE POLYMORPHISM WITH THE RISK OF PARKINSON'S DISEASE
    Borgohain, R.
    Syed, T.
    Syed, T. F.
    Meka, S. S. L.
    Kandadai, R. M.
    PARKINSONISM & RELATED DISORDERS, 2020, 79 : E31 - E32
  • [26] Dopamine D3 receptor in Parkinson's disease and schizophrenia
    Joyce, J
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S169 - S170
  • [27] Continuous dopamine-receptor stimulation in advanced Parkinson's disease
    Nutt, JG
    Obeso, JA
    Stocchi, F
    TRENDS IN NEUROSCIENCES, 2000, 23 (10) : S109 - S115
  • [28] Dopamine and adenosine receptor interaction as basis for the treatment of Parkinson's disease
    Simola, N
    Pinna, A
    Carta, AR
    Tronci, E
    Morelli, M
    PROCEEDINGS OF THE MENTAL DYSFUNCTIONS IN PARKINSON'S DISEASE, 2004, : 105 - 109
  • [29] PARKINSON'S DISEASE: WILL THERAPY MOVE BEYOND DOPAMINE RECEPTOR AGONISTS?
    Vecsei, L.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 8 - 9
  • [30] Continuous dopamine-receptor stimulation in early Parkinson's disease
    Olanow, CW
    Schapira, AHV
    Rascol, O
    TRENDS IN NEUROSCIENCES, 2000, 23 (10) : S117 - S126
12345